Keynote-158 study, FDA granted accelerated approval of pembrolizumab for the treatment of patients with advanced PD-L1-positive cervical cancer
@article{ATM46503,
author = {Edith Borcoman and Christophe Le Tourneau},
title = {Keynote-158 study, FDA granted accelerated approval of pembrolizumab for the treatment of patients with advanced PD-L1-positive cervical cancer},
journal = {Annals of Translational Medicine},
volume = {8},
number = {23},
year = {2020},
keywords = {},
abstract = {},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/46503}
}